We are live on ! Find out more
BIP

Brandes Investment Partners Portfolio holdings

AUM $14.1B
1-Year Est. Return 25.52%
This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+25.52%
3 Year Est. Return
+82.74%
5 Year Est. Return
+120.97%
10 Year Est. Return
+869.55%
AUM
$4.95B
AUM Growth
+$26.5M
Cap. Flow
-$33.6M
Cap. Flow %
-0.68%
Top 10 Hldgs %
36.09%
Holding
174
New
44
Increased
38
Reduced
76
Closed
13

Top Buys

Rank Stock Value
1
CX icon
Cemex
CX
+$76.2M
2
CLS icon
Celestica
CLS
+$40.4M
3
CAH icon
Cardinal Health
CAH
+$34.3M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$31M
5
WKC icon
World Kinect Corp
WKC
+$29.4M

Top Sells

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$108M
2
WDC icon
Western Digital
WDC
+$49.1M
3
ELOS
Syneron Medical Ltd
ELOS
+$31.9M
4
BAC icon
Bank of America
BAC
+$24.1M
5
TX icon
Ternium
TX
+$19.6M

Sector Composition

Rank Sector Weight
1 Financials 25.27%
2 Healthcare 17.84%
3 Industrials 11.48%
4 Energy 11.24%
5 Materials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNT
126
DELISTED
Verint Systems
VRNT
$1.58M 0.03%
73,954
-4,542
-6% -$97.7K
NKSH icon
127
National Bankshares
NKSH
$257M
$1.56M 0.03%
34,291
+4,792
+16% +$217K
NRIM icon
128
Northrim BanCorp
NRIM
$587M
$1.48M 0.03%
174,416
-35,808
-17% -$313K
TBNK
129
DELISTED
Territorial Bancorp Inc.
TBNK
$1.46M 0.03%
47,218
+20,378
+76% +$643K
ALEX
130
DELISTED
Alexander & Baldwin
ALEX
$1.43M 0.03%
51,405
-1,613
-3% -$62.9K
GWX icon
131
State Street SPDR S&P International Small Cap ETF
GWX
$912M
$1.2M 0.02%
+33,913
New +$1.2M
AVP
132
DELISTED
Avon Products, Inc.
AVP
$761K 0.02%
353,984
+105,649
+43% +$227K
ACWI icon
133
iShares MSCI ACWI ETF
ACWI
$33.3B
$640K 0.01%
+8,875
New +$628K
BBWI icon
134
Bath & Body Works
BBWI
$3.89B
$544K 0.01%
+11,182
New +$452K
GTE icon
135
Gran Tierra Energy
GTE
$317M
$410K 0.01%
15,196
– –
MD icon
136
Pediatrix Medical
MD
$2.12B
$324K 0.01%
+6,062
New +$286K
SPY icon
137
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$228K ﹤0.01%
+856
New +$223K
AMPE
138
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$204K ﹤0.01%
+167
New +$78.5K
ENPH icon
139
Enphase Energy
ENPH
$5.42B
$111K ﹤0.01%
+46,000
New +$96.3K
NVLN
140
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$109K ﹤0.01%
34,828
– –
WPRT
141
Westport Fuel Systems
WPRT
$35.7M
$108K ﹤0.01%
+2,860
New +$93K
APTO
142
DELISTED
Aptose Biosciences, Inc.
APTO
$95K ﹤0.01%
+94
New +$72.7K
IDXG
143
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$93K ﹤0.01%
+9,100
New +$110K
CGI
144
DELISTED
Celadon Group Inc
CGI
$83K ﹤0.01%
+13,000
New +$85.6K
HOS
145
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$81K ﹤0.01%
+26,000
New +$94.6K
CSCI
146
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$80K ﹤0.01%
+340
New +$70.8K
STRM
147
DELISTED
Streamline Health Solutions
STRM
$74K ﹤0.01%
+2,900
New +$66.6K
FCEL icon
148
FuelCell Energy
FCEL
$1.59B
$71K ﹤0.01%
+115
New +$79.8K
SEEL
149
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
SHIP icon
150
Seanergy Maritime Holdings
SHIP
$349M
$62K ﹤0.01%
+25
New +$64.8K
3 4 5
6
7

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brandes Investment Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Brandes Investment Partners held 174 positions worth $4.95B, up 0.54% from $4.92B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Brandes Investment Partners's Q4 2017 filing shows 44 new, 38 increased, 76 reduced and 13 closed positions. Its largest new stake was Celestica: 3,648,707 shares worth $38.2M. The largest sale was Willis Towers Watson, an estimated $108M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Brandes Investment Partners's largest Q4 2017 buy was Celestica: 3,648,707 shares worth $38.2M.
  • Brandes Investment Partners added most to Cemex in Q4 2017, an estimated $76.2M increase.
  • Brandes Investment Partners's biggest Q4 2017 reduction was Bank of America, cutting an estimated $24.1M.
  • Brandes Investment Partners fully exited Willis Towers Watson in Q4 2017, selling an estimated $108M.
  • Brandes Investment Partners's ten largest holdings make up 36% of its $4.95B portfolio in Q4 2017.
  • Brandes Investment Partners opened 44 new positions and closed 13 in Q4 2017.
  • Brandes Investment Partners's portfolio value rose 0.54% quarter-over-quarter to $4.95B.

Based on Brandes Investment Partners's 13F filing for Q4 2017, filed 12 Feb 2018.